BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21331942)

  • 1. Methodological aspects of multicenter studies with quantitative PET.
    Boellaard R
    Methods Mol Biol; 2011; 727():335-49. PubMed ID: 21331942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
    Metser U; Even-Sapir E
    Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma.
    Quon A; Fischbein NJ; McDougall IR; Le QT; Loo BW; Pinto H; Kaplan MJ
    J Nucl Med; 2007 Jan; 48 Suppl 1():58S-67S. PubMed ID: 17204721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies.
    Nanni C; Pettinato C; Ambrosini V; Spinelli A; Trespidi S; Rubello D; Al-Nahhas A; Franchi R; Alavi A; Fanti S
    Nucl Med Commun; 2007 Jul; 28(7):547-53. PubMed ID: 17538396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (18)F-FDG-PET/CT of orofacial tumors, a value of whole-body imaging approach.
    Ferda J; Ferdová E; Záhlava J; Walter J; Mukensnabl P; Daum O; Kreuzberg B
    Eur J Radiol; 2010 Feb; 73(2):241-8. PubMed ID: 19101104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PET/CT for the staging and follow-up of patients with malignancies.
    Poeppel TD; Krause BJ; Heusner TA; Boy C; Bockisch A; Antoch G
    Eur J Radiol; 2009 Jun; 70(3):382-92. PubMed ID: 19406595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.
    Uesaka D; Demura Y; Ishizaki T; Ameshima S; Miyamori I; Sasaki M; Fujibayashi Y; Okazawa H
    J Nucl Med; 2008 Oct; 49(10):1606-12. PubMed ID: 18794269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
    Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
    Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.
    Boellaard R; Oyen WJ; Hoekstra CJ; Hoekstra OS; Visser EP; Willemsen AT; Arends B; Verzijlbergen FJ; Zijlstra J; Paans AM; Comans EF; Pruim J
    Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2320-33. PubMed ID: 18704407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of quantifying 18F-FDG uptake in thyroid nodules found incidentally on whole-body PET-CT.
    Bogsrud TV; Karantanis D; Nathan MA; Mullan BP; Wiseman GA; Collins DA; Kasperbauer JL; Strome SE; Reading CC; Hay ID; Lowe VJ
    Nucl Med Commun; 2007 May; 28(5):373-81. PubMed ID: 17414887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-body 18F-FDG PET/CT: the need for a standardized field of view--a referring-physician aid.
    Huston SF; Abdelmalik AG; Nguyen NC; Farghaly HR; Osman MM
    J Nucl Med Technol; 2010 Sep; 38(3):123-7. PubMed ID: 20724533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and patterns of physiologic muscle uptake detected with whole-body 18F-FDG PET.
    Jackson RS; Schlarman TC; Hubble WL; Osman MM
    J Nucl Med Technol; 2006 Mar; 34(1):29-33. PubMed ID: 16517966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
    Brown C; Dempsey MF; Gillen G; Elliott AT
    Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redistribution of whole-body energy metabolism by exercise: a positron emission tomography study.
    Masud MM; Fujimoto T; Miyake M; Watanuki S; Itoh M; Tashiro M
    Ann Nucl Med; 2009 Jan; 23(1):81-8. PubMed ID: 19205842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving role of 18F-FDG-PET/CT for the body tumor and metastases in pediatrics.
    Chen Z; Li X; Li F; Ouyang Q; Yu T
    Eur J Radiol; 2010 Sep; 75(3):329-35. PubMed ID: 20576385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
    Beyer T; Bockisch A; Kühl H; Martinez MJ
    J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Treadmill exercise does not affect image quality on subsequent whole body FDG PET scan".
    Spirnak J
    J Nucl Med; 2011 Dec; 52(12):2020. PubMed ID: 22068896
    [No Abstract]   [Full Text] [Related]  

  • 18. Interim positron emission tomography scan in multi-center studies: optimization of visual and quantitative assessments.
    Zijlstra JM; Boellaard R; Hoekstra OS
    Leuk Lymphoma; 2009 Nov; 50(11):1748-9. PubMed ID: 19863171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standards for PET image acquisition and quantitative data analysis.
    Boellaard R
    J Nucl Med; 2009 May; 50 Suppl 1():11S-20S. PubMed ID: 19380405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of PET normalization: striving for count rate uniformity.
    Theodorakis L; Loudos G; Prassopoulos V; Kappas C; Tsougos I; Georgoulias P
    Nucl Med Commun; 2013 Nov; 34(11):1033-45. PubMed ID: 24048410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.